See the DrugPatentWatch profile for Carboplatin
The trade name for carboplatin is Paraplatin [1].
What is carboplatin used to treat?
Carboplatin is a chemotherapy drug used to treat various types of cancer, including ovarian cancer, lung cancer, and head and neck cancer [2]. It works by interfering with the growth of cancer cells, which are then destroyed [2].
How is carboplatin administered?
Carboplatin is typically administered intravenously [2]. The dosage and duration of treatment depend on the specific type and stage of cancer, as well as the patient's overall health [2].
What are the common side effects of carboplatin?
Common side effects of carboplatin include nausea, vomiting, hair loss, and bone marrow suppression, which can lead to an increased risk of infection and bleeding [2]. More serious side effects can occur, and patients should discuss any concerns with their healthcare provider [2].
What is the difference between carboplatin and cisplatin?
Carboplatin and cisplatin are both platinum-based chemotherapy drugs, but they differ in their chemical structure and toxicity profile [3]. Carboplatin is generally considered less toxic than cisplatin, particularly in terms of kidney damage and nerve damage [3]. However, carboplatin may cause more significant bone marrow suppression [3].
When does the patent for carboplatin expire?
Information regarding specific patent expiry dates for carboplatin and its trade names can be found through resources that track drug patents [4]. DrugPatentWatch.com provides detailed patent information and expiry timelines for pharmaceutical products [4].